Showing results (371-380 of 409) with videos related to

Sort By:
Pageof 41
British Journal of Cancer|February 24, 2005
Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancerS C Oh, K H Park, I K Choi, et al.
Stroke|June 30, 2012
Elderly patients are at higher risk for poor outcomes after intra-arterial therapyRonil V Chandra, Thabele M Leslie-Mazwi, Daniel C Oh, et al.
Biomacromolecules|May 9, 2025
Applying Computational Protein Design to Engineer Affibodies for Affinity-controlled Delivery of Vascular Endothelial Growth Factor and Platelet-Derived Growth FactorJustin E Svendsen, Madeleine R Ford, Chandler L Asnes, et al.
Singapore Medical Journal|August 1, 2013
Health promotion board-ministry of health clinical practice guidelines: treating tobacco use and dependenceK Chan, J Chandler, K Cheong, et al.
Plos Genetics|May 31, 2014
Discovery and functional annotation of SIX6 variants in primary open-angle glaucomaMegan Ulmer Carnes, Yangfan P Liu, R Rand Allingham, et al.
European Review for Medical and Pharmacological Sciences|September 11, 2012
Anti-inflammatory effects of Hylomecon hylomeconoides in RAW 264.7 cellsH S Chae, O H Kang, J H Keum, et al.
British Journal of Cancer|May 3, 2007
A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancerS C Oh, H Y Sur, H J Sung, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 8, 2013
Development and plasticity of outer retinal circuitry following genetic removal of horizontal cellsPatrick W Keeley, Gabriel Luna, Robert N Fariss, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2020
Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 studyE Van Cutsem, K Muro, D Cunningham, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 5, 2012
Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatmentJ Kwun, B C Oh, A C Gibby, et al.
Pageof 41